PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
Purple Biotech (NASDAQ:PPBT) was downgraded by analysts at Wall Street Z
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification
Purple Biotech Receives Intention to Grant a European Patent Covering NT219 Combinations with Immunotherapies or MEK Inhibitors to Overcome Tumor Resistance [Yahoo! Finance]
Form 6-K PURPLE BIOTECH LTD. For: Nov 19
Form 6-K PURPLE BIOTECH LTD. For: Nov 14
Form SCHEDULE 13G/A PURPLE BIOTECH LTD. Filed by: INTRACOASTAL CAPITAL, LLC
Form 6-K PURPLE BIOTECH LTD. For: Oct 29
Form 6-K PURPLE BIOTECH LTD. For: Oct 28
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.